CorMedix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CorMedix and other ETFs, options, and stocks.About CRMD
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E.
CEOJoseph Todisco
CEOJoseph Todisco
Employees65
Employees65
HeadquartersBerkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded2006
Founded2006
Employees65
Employees65
CRMD Key Statistics
Market cap761.10M
Market cap761.10M
Price-Earnings ratio4.70
Price-Earnings ratio4.70
Dividend yield—
Dividend yield—
Average volume3.29M
Average volume3.29M
High today$9.67
High today$9.67
Low today$9.30
Low today$9.30
Open price$9.44
Open price$9.44
Volume2.18M
Volume2.18M
52 Week high$17.43
52 Week high$17.43
52 Week low$5.60
52 Week low$5.60
Stock Snapshot
CorMedix(CRMD) stock is priced at $9.66, giving the company a market capitalization of 761.1M. It carries a P/E multiple of 4.70.
On 2025-11-28, CorMedix(CRMD) stock moved within a range of $9.30 to $9.67. With shares now at $9.66, the stock is trading +3.9% above its intraday low and -0.1% below the session's peak.
Trading activity shows a volume of 2.18M, compared to an average daily volume of 3.29M.
The stock's 52-week range extends from a low of $5.60 to a high of $17.43.
The stock's 52-week range extends from a low of $5.60 to a high of $17.43.
CRMD News
Simply Wall St 2d
CorMedix Is Down 6.3% After Strong Q3 Results and $87.6M Shelf Registration FiledCorMedix Inc. recently reported a very large increase in third-quarter revenue and net income, issued positive guidance for the fourth quarter, and filed an US$...
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CRMD. This list is generated using Robinhood data, and it’s not a recommendation.